#AntagTherapeutics #Antag #weightlosstherapy #VersantVentures #drugdevelopment #SeriesAfinancing #AT7687 #obesity #NovoHoldings #SROne #DawnBiopharma #Pictet #INDclearance #GlucoseDependentInsulinotropicPolypeptideReceptor #InvestigationalNewDrugapplication
pharmatimes.com/news/antag-t...
0
0
0
0